Professor Lotte Steuten is Head of Consulting and Vice President of the Office of Health Economics.
Lotte’s research interest focuses on the development and application of health economic analysis and health technology assessment (HTA), with the aim to accelerate patient access to high value health care services and treatments. She specializes in quantitative methods for estimating and comparing the expected health and economic benefits of new approaches and interventions in disease prevention, diagnostics and treatment, and prioritizing data collection to efficiently build the evidence for new interventions.
After obtaining her PhD she has acquired >10 years of international expertise in leading health economics and HTA projects to inform a wide range of decision problems, working effectively with various academic and non-academic stakeholders including patients, care providers, payers, policy makers, innovators and manufacturers.
Prior to joining OHE, Lotte was an associate member at the Hutchinson Institute for Cancer Outcomes Research (HICOR) at the Fred Hutchinson Cancer Research Center, and an affiliate associate professor in the Comparative Health Outcomes, Policy, and Economics (CHOICE) Institute at the University of Washington, Seattle. She co-founded Panaxea bv, a health innovation consultancy firm with offices in the Netherlands, Belgium and Germany, and served as its Chief Executive and Scientific Officer for nearly 10 years.
Previously, Lotte has worked as (senior) investigator at well-known health economic departments of universities in the UK (Health Economics Research Group, Brunel University, London) and the Netherlands (Twente University and Maastricht University) where she conducted numerous studies varying from the early assessment of specialized medical technologies to full economic evaluation of chronic care programs. In various roles she was responsible for developing, leading and conducting health economic research programs and was director of a health sciences graduate education program. Lotte serves on the ISPOR Value of Information TaskForce and on the editorial board of various academic journals. She has an MSc and PhD (cum laude) from Maastricht University, the Netherlands and is currently an Honorary Professor at City University, London as of 1 April 2019.
Lotte has published nearly 100 original peer reviewed journal articles and is the editor of a textbook on the Economics of Personalized Medicine (forthcoming in 2019). She is a frequent presenter and panelist at conferences on health innovation and economics worldwide.
SPEAKER: ADAPTIVE PATHWAYS: GENERATING EVIDENCE OF VALUE